Skip to content

The effect of sweet almond oil on the pruritus and quality of life in hemodialysis patients

The effect of topical application of sweet almond oil on the uremic pruritus and itchy quality of life in hemodialysis patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014121520313N1
Enrollment
42
Registered
2015-02-06
Start date
2013-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uremic pruritus. Other pruritus

Interventions

Intervention 1: Control group : Received no specific intervention . Intervention 2: Intervention group : From sweet almond oil made by Iranian Barij Essence pharmaceutical company with License registr
Treatment - Drugs
Intervention group : From sweet almond oil made by Iranian Barij Essence pharmaceutical company with License registration number “ s – 90 – 050 “ was used. This oil is contained from 77% oleic acid a

Sponsors

Yasuj University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 87 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: participant is known cace of Chronic Renal Disease and under hemodialysis therapy at least 6months; suffering from pruritus to arise Chronic Renal Disease at least 2weeks; participant has only suffering from Chronic Renal Disease and has not suffering from known cace of pruriginous dermal disease; participant has age more than 18years; participant is healthy Psychologically; participant has not conscious disorder; participant has not speaking disorder; participant has not hearing disorder; participant has not seeing disorder; participant has informed tendency to participate in study. Exclusion criteria: participant express noninclination to participate in study in any stage of study; participant do not to apply sweet almond oil during the study; participant dies during the study; participant emigrates from study invironment during the study; participant receive renal transplant during the study; participant being under long term treatment with antihistamines or other pruritus sedative Medications during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Uremic pruritus. Timepoint: one week pre-intervention , the end of the first week after intervention and the end of the second week after intervention. Method of measurement: severity scale questionnaire.;Itchy quality of life. Timepoint: one week pre-intervention , the end of the first week after intervention and the end of the second week after intervention. Method of measurement: Itchy quality of life questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Mehri

Yasuj University of Medical Science

zahra.mehri@yums.ac.ir - afagh313@gmail.com - afagh313@chmail.com+98 74 3323 3701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026